Dr Laurie Sehn from the BC Cancer Center for Lymphoid Cancer in Vancouver, Canada, discusses the latest clinical research findings on non-Hodgkin and Hodgkin lymphomas from the 2020 ASH Annual Meeting.

CME information and select publications here.

Dr Natalie Callander from the University of Wisconsin Carbone Cancer Center discusses key presentations on multiple myeloma, Waldenström macroglobulinemia and amyloidosis from the 2020 ASH Annual Meeting.

CME information and select publications here.

Dr Roberto Iacovelli from the Fondazione Policlinico Universitario A Gemelli in Rome discusses the spectrum and management of side effects with hormonal therapies in prostate cancer.

CME information and select publications here.

Dr Harry Erba from Duke University in Durham, North Carolina, discusses key presentations on acute myeloid leukemia and myelodysplastic syndromes from the 2020 AS Annual Meeting.

CME information and select publications here.

Dr Manmeet Ahluwalia from the Miami Cancer Institute of Baptist Health South Florida discusses recently published and emerging research on the management of CNS metastases in patients with non-small cell lung cancer.

CME information and select publications here.

Dr Gilles Salles from Memorial Sloan Kettering Cancer Center in New York discusses recently published and emerging research on the treatment of diffuse large B-cell lymphoma.

CME information and select publications here.

Dr Andrew Wei from the Alfred Hospital and Monash University in Melbourne, Australia, discusses recently published and emerging research on the treatment of acute myeloid leukemia not eligible for intensive induction therapy.

CME information and select publications here.

Dr Antonio González-Martín from the Clínica Universidad de Navarra in Madrid discusses the latest clinical data on and optimal integration of PARP inhibitors in ovarian cancer.

CME information and select publications here.

Professor Solange Peters from Lausanne University Hospital in Switzerland discusses existing and emerging biomarkers of response to cancer immunotherapy.

CME information and select publications here.

Dr Joseph Mikhael from the Translational Genomics Research Institute in Phoenix, Arizona, discusses agents that have been recently approved for the treatment of multiple myeloma.

CME information and select publications here.